Peru’s fight against tuberculosis demonstrates how global neglect endangers public health. COVID-19 setbacks, poverty, and ...

Ad hoc announcement pursuant to Art. 53LRBASEL, Switzerland, Dec. 11, 2025 (GLOBE NEWSWIRE) -- BV100 Phase 3 in Ventilator Associated ...

Noting alarming reports showing a steady rise in the incidence of TB infections and deaths, Senator Risa Hontiveros on Tuesday pressed her advocacy for ramping up the fight against the dreaded ...

Objectives Bedaquiline (BDQ), delamanid (DLM) and pretomanid (Pa) were widely used in recent years. This study aimed to analyse adverse drug event (ADE) reports associated with them based on the Food ...

Zimbabwe has made significant strides in reducing the national tuberculosis (TB) burden, yet stigma surrounding the disease remains alarmingly high, outpacing ...

Drug-resistant tuberculosis (DR-TB) heavily contributes to the global challenge of antimicrobial resistance (AMR), resulting in increased morbidity among tuberculosis cases. The Association of ...

Tuberculosis killed 1.23 million people in 2024, making it the world’s deadliest infectious disease despite being preventable and treatable. The new WHO Global Tuberculosis Report 2025 shows that 10.7 ...

India accounted for most number of Tuberculosis cases in 2024, followed by Indonesia, the Philippines, China, and Pakistan, said a recent report from the World Health Organisation. The international ...

A 2-stage approach to linezolid dosing appeared best-suited for balancing bactericidal activity, sterilizing efficacy, and adverse events. In multidrug-resistant or rifampicin-resistant tuberculosis ...

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. James A Seddon and ...

Objectives Young contacts of pulmonary tuberculosis (TB) patients face a higher risk of TB. Still, few studies have evaluated this risk among contacts of patients with pulmonary multidrug-resistant ...

ABSTRACT: Background: Tuberculosis (TB) remains a major health challenge in Mozambique, which continues to rank among the top 30 high-burden countries for TB, TB/HIV co-infection, and drug-resistant ...